Medical Image Understanding and Analysis Conference 2020 Jul 15, 2020 - Jul 17, 2020 — Virtual Meeting (online)
CAFACHEM 2020 Summer School on Organic & Halogen Radiochemistry Aug 26, 2020 - Aug 28, 2020 — Virtual Meeting (online)
Scottish Dementia Research Consortium Annual Conference 2020 [rescheduled] Sep 07, 2020 10:00 AM - 04:00 PM — Radisson Blu, 301 Argyle St, Glasgow
Society for Magnetic Resonance Angiography - SMRA2020 VIRTUAL Sep 11, 2020 - Sep 13, 2020 — Virtual Meeting (online)


SINAPSE experts from around Scotland have developed ten online modules designed to explain medical imaging. They are freely available and are intended for non-specialists.

Edinburgh Imaging Academy at the University of Edinburgh offers the following online programmes through a virtual learning environment:

Neuroimaging for Research MSc/Dip/Cert

Imaging MSc/Dip/Cert

PET-MR Principles & Applications Cert

Applied Medical Image Analysis Cert

Online Short Courses

Research governance impediments to clinical trials: a retrospective survey

Author(s): Rustam Al-Shahi Salman, Timothy M. Brock, Martin S. Dennis, Peter A. G. Sandercock, Philip M. White, Charles Warlow

OBJECTIVE: We sought to evaluate the delays, between-centre variations in practice, and opportunity costs attributable to delays in research governance approval of clinical trials in the United Kingdom. DESIGN: Retrospective survey. SETTING: Research and Development (R&D) departments at 50 UK National Health Service hospital trusts governing 57 hospital sites. PARTICIPANTS: R&D departments participating in four randomized multicentre clinical trials coordinated by our Neurosciences Trials Unit. INTERVENTIONS: None. MAIN OUTCOME MEASURES: Median delay between application and research governance approval. RESULTS: Only half of the R&D departments used the UK online R&D form. Only a single copy of the application was required by 96% of R&D departments. The median delay between application and research governance approval was 44 working days (inter-quartile range 23-80). A delay of >20 working days was incurred by 43 applications (75%), of which 24 (56%) were not explicable and 11 (20%) were attributable to local funding negotiations. Based on the trial randomization rates at each centre, 108 patients (17% of all patients randomized) could have been randomized during the delay, at a crude cost to funding agencies of 53,743 pounds; if a four week delay was deemed acceptable, 75 patients (12% of all patients randomized) could have been randomized during unacceptable delays, at a crude cost to funding agencies of 37,700 pounds. CONCLUSIONS: The UK research governance system incurs unacceptably long and costly delays for clinical trials. Urgent reform is needed, including rapid design and uniform implementation of the 'bureaucracy busting' measures in Best Research for Best Health.

Full version: Available here

Click the link to go to an external website with the full version of the paper

ISBN: 0141-0768
Publication Year: 2007
Periodical: J R Soc Med
Periodical Number: 2
Volume: 100
Pages: 101-4
Author Address: